vpp activities - ias satellite session july 2012 final

Shared by: fjzhangweiyun
Categories
Tags
-
Stats
views:
0
posted:
2/1/2013
language:
English
pages:
15
Document Sample
scope of work template
							Voluntary Pooled Procurement (VPP) – Is
it meeting our expectations?



IAS 2012 Conference, Washington D.C.
Satellite Session on VPP , 22 nd July 2012
PRESENTATION OUTLINE
• Rationale for VPP - Objectives

• Current status – meeting expectations
  – Achievements
  – Challenges


• Looking forward – making VPP more
  efficient
RATIONALE FOR VOLUNTARY
POOLED PROCUREMENT –
OBJECTIVES
Procurement and Supply Management
Highest areas of risk

                                    Extract from Final Report of
                                    the High-Level Independent
                                    Review Panel on Fiduciary
                                    Controls and Oversight
                                    Mechanisms of the Global
                                    Fund (September 2011),
                                    Annex E: Procurement,
                                    Construction and Supply-
                                    chain Management
                                    (PCSCM) weaknesses




Use of the Global Fund Grants
    Over 37 percent of funds are
     used for health products
Market Dynamics / Shaping Strategies – Leveraging
purchasing power to improve Market outcomes and Impact

       IMPACT             MARKET OUTCOMES                         GLOBAL FUND
                                                                  COMMITMENTS
                              Lowest
                            sustainable                9
   Increased product          prices
 access & health impact                                8


                                                       7
                            Consistent
                            high quality               6




                                            Billions
                                                       5
    Improved patient         Sustained
     outcomes reduced
 outcomes (eg,(e.g.          adequate                  4
  reduced side-effects)
      side-effects)           supply
                                                       3


                              Optimal                  2
                              product
                              design                   1

   Improved value for                                  -




                                                           2002




                                                                                2005



                                                                                              2007




                                                                                                                   2010
                                                                  2003

                                                                         2004



                                                                                       2006



                                                                                                     2008

                                                                                                            2009



                                                                                                                          2011
        money               Rapid access
                               to new
                              products                      Cumulative Health Product Financing
Voluntary Pooled Procurement – Objectives
   Market Dynamics / Shaping interventions
      Influencing market of core health products to impact price, quality,
       supply sustainability and design;
      Implementing targeted market shaping interventions – for example to
       secure the fragile pediatric ARV Market (small market and high risk)


   Grant performance
     • Addressing and resolving PSM challenges impeding grant
       implementation


   Risk mitigation
     • Mitigating financial and PSM related risks
VPP MEETING EXPECTATIONS
– ACHIEVEMENTS AND
CHALLENGES
Global Fund: Voluntary Pooled Procurement:
June 2009- December 2011
                                  Value of Confirmed Orders (US$):




          People reached:
 - 57 million courses of ACTs
  - 336,000 people receiving
                         ARVs
   - 10 million HIV rapid tests
    - 27 million malaria rapid
                          tests
 - 90 million insecticidal nets
VPP - 90 Million LLINs
Savings of > US$38 million (16%)*




       lowest price achieved = US$ 2.80 (Liberia)


        Cameroon, 2011
        8.5 million LLINs and savings of US$
        5.7 million through managing the
        procurement and support to the PR
        to receive and distribute 500
        containers of LLINS

 *   Compared to budget based ; subset of largest transactions 2009-2011
VPP - 307 Million Doses ARVs
Savings of > US$11 million (17%)*
      Unit Prices
      •  3% in the last year
      • 14% below 2012 CHAI negotiated
        ceiling price
      Delivery timelines
      •  15% with 50% delivered in less
        than 5 months



      Uganda 2011/2
      Procurement costs reduced by U$2.3
      million (16%) through timely order
      placement and alignment of the
      procurement and financing timelines to
      obtain lowest available pricing and to
      be able to utilize sea/road freight

 *   Compared to budget based ; subset of largest transactions 2009-2011
Challenges
• Demand aggregation – irregular participation of PRs; Global Fund
  grant architecture (multiple grants); individual (multiple) PSM plans
  and non-coordinated procurement cycles;


• Emergency Orders - inadequate procurement planning; Use of
  VPP as “last resort”;


• Expectations from PRs – quicker results, especially unrealistic
  delivery times; resolution of long-standing PSM bottlenecks or
  Condition Precedent (CPs) on grants; abdication of responsibility
• Non-core products (Drugs for opportunistic infections; lab supplies)
  – low volume / low value; difficult to source; non-quality assurance
  standards; region specific, and non-focus for VPP

                                                                      11
VPP – MAKING IT MORE
EFFICIENT
VPP Procurement Process
             Procurement                               Procurement
               Request                                   Request
 Principal                      VPP team                              Procurement
                           (value for money aspects,
 Recipient                     budget, CPs etc.)                         agent



                            VPP: oversight                           Price Quotation     PR approval


                                Direct                                PSA confirms
                            disbursement                             order to supplier


                                                                        Delivery           PR clears /
                                                                                         confirms receipt
                                                                                            of goods

                                                                     Final invoice &
                                                                      reconciliation


                                                                     PQR data entry
VPP Mechanism to be more efficient




    • EXPECTATIONS                    • REQUIREMENTS
 • Cost efficient procurement    • PRs and Procurement Agents
                                    meeting their responsibilities
               +
                                                +
• Improved grant performance
                                  • Improved VPP financial and
               +
                                       operational procedures
• Procurement & financial risk
                                                +
            mitigation
                                   • Support from partners and
                                           stakeholders
Opportunities for shorter timelines & value for money
                                                           Payment
               Product          Competitive     PR                                        Shippin
                                                          disburseme      Manufacture
             specifications      process      approval        nt                             g

Optimal
 time            1-2              1            1            0             2–6             2-8
                               (long term                (separate      (negotiated     (air/sea)
= 7 - 18                      agreements)                 account)     commitments)
weeks
 Current
best case          1               1           1             1               1              2
   = 7                                                                   (available
                                                                           stock)         (air)
 weeks

Current
                  1-2              2           2             4              8             2-8
“norm”
= 19-26                                                                                 (air/sea)
weeks
 Current
  “bad”                                                                                     8
                    6              4          12 +         12 ++            12
case: = 56                                                                                (sea)
  weeks                                                         Early procurement planning &
                    For new grants/phases, tendering
                    can happen pre-signing = saving                    proactive management
                          1-2 months (or more)                   > 5% reductions in unit price
                                                             > 10% reductions in freight costs
 National procurement                                                        risk of stock-out
 typically 21-78 weeks

						
Related docs
Other docs by fjzhangweiyun
the house of bernarda alba
Views: 1  |  Downloads: 0
The Diamond Rush- How It All Began
Views: 2  |  Downloads: 0
The Diagnosis - The Sonny _ Mike Page
Views: 2  |  Downloads: 0
The Community Infrastructure Levy
Views: 2  |  Downloads: 0
The Blessing Way.rtf
Views: 1  |  Downloads: 0
The Bench.rtf
Views: 1  |  Downloads: 0